These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 6951095)

  • 1. Comparison of in vitro and in vivo effects of thymidine on L1210 leukemia in mice.
    Zaharko DS; Ramonas LM
    J Natl Cancer Inst; 1982 May; 68(5):875-80. PubMed ID: 6951095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of deoxycytidine metabolism in vivo with high-dose thymidine in mice.
    Zaharko DS; Covey JM
    J Natl Cancer Inst; 1983 Nov; 71(5):1033-9. PubMed ID: 6580479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose- and schedule-dependent activation and drug synergism between thymidine and 5-aza-2'-deoxycytidine in a human promyelocytic leukemia cell line.
    Grant S; Rauscher F; Margolin J; Cadman E
    Cancer Res; 1982 Feb; 42(2):519-24. PubMed ID: 6173114
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo enhancement of 5-fluorouracil cytotoxicity to AKR leukemia cells by thymidine in mice.
    Santelli G; Valeriote F
    J Natl Cancer Inst; 1978 Sep; 61(3):843-7. PubMed ID: 278862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic and cytokinetic effects of thymidine, 5-fluorouracil, and deoxycytidine on HeLa cells in culture.
    Fried J; Perez AG; Doblin JM; Clarkson BD
    Cancer Res; 1981 Jul; 41(7):2627-32. PubMed ID: 7248935
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 2',3'-Dideoxycytidine: regulation of its metabolism and anti-retroviral potency by natural pyrimidine nucleosides and by inhibitors of pyrimidine nucleotide synthesis.
    Balzarini J; Cooney DA; Dalal M; Kang GJ; Cupp JE; DeClercq E; Broder S; Johns DG
    Mol Pharmacol; 1987 Dec; 32(6):798-806. PubMed ID: 2826994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of in vivo and in vitro effects of continuous exposure of L1210 cells to 6-thioguanine.
    Maybaum J; Morgans CW; Hink LA
    Cancer Res; 1987 Jun; 47(12):3083-7. PubMed ID: 3581060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of deoxynucleosides on cultured human leukemia cell growth and deoxynucleotide pools.
    Ross DD; Akman SA; Schrecker AW; Bachur NR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4493-8. PubMed ID: 6975653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential affinities of pyrimidine nucleoside analogues for deoxythymidine and deoxycytidine kinase determine their incorporation into murine leukemia L1210 cells.
    Balzarini J; De Clercq E
    Acta Biochim Pol; 1987; 34(2):63-77. PubMed ID: 2823514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of deoxycytidine kinase in the inhibitory activity of 5-substituted 2'-deoxycytidines and cytosine arabinosides on tumor cell growth.
    Balzarini J; De Clercq E
    Mol Pharmacol; 1983 Jan; 23(1):175-81. PubMed ID: 6306422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic action of 5-aza-2'-deoxycytidine and 3-deazauridine on L1210 leukemic cells and EMT6 tumor cells.
    Momparler RL; Veselý J; Momparler LF; Rivard GE
    Cancer Res; 1979 Oct; 39(10):3822-7. PubMed ID: 476619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of poly(adenosine diphosphate-ribose) polymerase by thymidine and thymidine analogues in L1210 cells and its relationship to the potentiation of the antitumor activity of 1,3-bis(2-chloroethyl)-1-nitrosourea but not of 3'-[3-(2-chloroethyl)-3-nitrosoureido]-3'-deoxythymidine.
    August EM; Cooper DL; Prusoff WH
    Cancer Res; 1991 Mar; 51(6):1586-90. PubMed ID: 1900213
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of anti-metabolite effects. Effects of thymidine on the efficacy of the quinazoline-based thymidylate synthetase inhibitor, CB3717.
    Jackman AL; Taylor GA; Calvert AH; Harrap KR
    Biochem Pharmacol; 1984 Oct; 33(20):3269-75. PubMed ID: 6487375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deoxyribonucleoside-induced selective modulation of cytotoxicity and mutagenesis.
    Peterson AR; Danenberg PV; Ibric LL; Peterson H
    Basic Life Sci; 1985; 31():313-34. PubMed ID: 3158302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of tumor cell heterogeneity of a murine leukemia cell line (L1210) in response to arabinosylcytosine: quantitation using a computerized image analysis system.
    Raymakers RA; Slocum HK; Minderman H; Malmberg M; Rustum YM
    Exp Hematol; 1993 May; 21(5):602-7. PubMed ID: 8513859
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of uridine rescue to enhance the antitumor selectivity of 5-fluorouracil.
    Klubes P; Cerna I
    Cancer Res; 1983 Jul; 43(7):3182-6. PubMed ID: 6850628
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved therapeutic index with high-dose methotrexate: comparison of thymidine-purine rescue with citrovorum factor rescue in mice.
    Samuels LL; Straw JA
    Cancer Res; 1984 Jun; 44(6):2278-84. PubMed ID: 6609764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rescue of thymidine cytotoxicity in L1210 ascites by elevated endogenous levels of deoxycytidine.
    Egan EM; Sargent L; Rosowsky A; Kufe DW
    Cancer Treat Rep; 1981; 65(9-10):853-60. PubMed ID: 7273018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of dose and duration of exposure on 5-aza-2'-deoxycytidine cytotoxicity for L1210 leukemia in vitro.
    Covey JM; Zaharko DS
    Cancer Treat Rep; 1984 Dec; 68(12):1475-81. PubMed ID: 6210141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects on the monocyte-macrophage system and antitumor activity against L1210 leukemia of cis-bis-cyclopentenecarboxylato-trans-R,R-1,2-diaminocyclohexane -platinum (II) encapsulated in multilamellar vesicles.
    Perez-Soler R; Khokhar AR; Claringbold P; Kasi LP; Lopez-Berestein G
    J Natl Cancer Inst; 1986 Nov; 77(5):1137-43. PubMed ID: 2430132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.